Concepts (146)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Drug Delivery Systems | 6 | 2021 | 2219 | 1.320 |
Why?
|
Nanoparticles | 8 | 2021 | 1905 | 1.290 |
Why?
|
von Willebrand Factor | 2 | 2020 | 669 | 1.090 |
Why?
|
Platelet Adhesiveness | 3 | 2020 | 161 | 0.890 |
Why?
|
Platelet Membrane Glycoproteins | 2 | 2021 | 293 | 0.880 |
Why?
|
Pregnenolone Carbonitrile | 1 | 2022 | 1 | 0.860 |
Why?
|
Models, Cardiovascular | 5 | 2021 | 996 | 0.840 |
Why?
|
Intracranial Aneurysm | 2 | 2020 | 1197 | 0.710 |
Why?
|
Carotid Artery Injuries | 1 | 2020 | 96 | 0.710 |
Why?
|
Blood Platelets | 7 | 2021 | 2509 | 0.690 |
Why?
|
Arteries | 2 | 2021 | 1119 | 0.670 |
Why?
|
Carotid Arteries | 2 | 2020 | 950 | 0.640 |
Why?
|
Thrombosis | 5 | 2021 | 2968 | 0.640 |
Why?
|
Fibrinolytic Agents | 4 | 2021 | 2158 | 0.590 |
Why?
|
Hemodynamics | 7 | 2022 | 4196 | 0.580 |
Why?
|
Microfluidics | 1 | 2022 | 662 | 0.560 |
Why?
|
Endothelial Cells | 4 | 2022 | 3486 | 0.490 |
Why?
|
Arterial Occlusive Diseases | 2 | 2015 | 793 | 0.480 |
Why?
|
Atherosclerosis | 2 | 2020 | 3444 | 0.470 |
Why?
|
Coronary Stenosis | 1 | 2019 | 834 | 0.440 |
Why?
|
Constriction, Pathologic | 1 | 2016 | 1107 | 0.440 |
Why?
|
Nanomedicine | 1 | 2015 | 304 | 0.420 |
Why?
|
Mesenteric Vascular Occlusion | 1 | 2012 | 97 | 0.410 |
Why?
|
Platelet Aggregation | 3 | 2021 | 798 | 0.340 |
Why?
|
Stress, Mechanical | 4 | 2021 | 1686 | 0.340 |
Why?
|
Nanotechnology | 1 | 2015 | 710 | 0.330 |
Why?
|
Shear Strength | 2 | 2021 | 165 | 0.310 |
Why?
|
Pulsatile Flow | 2 | 2019 | 332 | 0.310 |
Why?
|
Tissue Engineering | 3 | 2022 | 1880 | 0.280 |
Why?
|
Biomimetic Materials | 2 | 2021 | 179 | 0.270 |
Why?
|
Tissue Plasminogen Activator | 1 | 2012 | 1261 | 0.270 |
Why?
|
Hemostasis | 3 | 2021 | 458 | 0.230 |
Why?
|
Hydrodynamics | 2 | 2020 | 158 | 0.210 |
Why?
|
Particle Size | 3 | 2021 | 1642 | 0.210 |
Why?
|
Computers, Molecular | 1 | 2021 | 14 | 0.200 |
Why?
|
Respiratory System Agents | 1 | 2021 | 29 | 0.200 |
Why?
|
Fibrinolysin | 1 | 2021 | 131 | 0.200 |
Why?
|
Microbial Consortia | 1 | 2021 | 32 | 0.200 |
Why?
|
Nanocapsules | 2 | 2012 | 91 | 0.190 |
Why?
|
Erythrocytes | 2 | 2022 | 2455 | 0.180 |
Why?
|
Adhesives | 1 | 2020 | 61 | 0.180 |
Why?
|
Time-Lapse Imaging | 1 | 2021 | 195 | 0.180 |
Why?
|
Immunoglobulin Fc Fragments | 1 | 2021 | 279 | 0.180 |
Why?
|
Pulmonary Embolism | 1 | 2012 | 2375 | 0.170 |
Why?
|
Apyrase | 1 | 2021 | 364 | 0.170 |
Why?
|
Synthetic Biology | 1 | 2021 | 179 | 0.170 |
Why?
|
Tissue Scaffolds | 3 | 2022 | 956 | 0.170 |
Why?
|
Capillaries | 1 | 2022 | 773 | 0.160 |
Why?
|
Bioreactors | 1 | 2019 | 236 | 0.160 |
Why?
|
Arginine | 1 | 2021 | 944 | 0.150 |
Why?
|
Drug Carriers | 2 | 2019 | 693 | 0.150 |
Why?
|
Fibrinogen | 1 | 2020 | 894 | 0.150 |
Why?
|
Motion | 1 | 2020 | 798 | 0.140 |
Why?
|
Platelet Activation | 1 | 2020 | 674 | 0.140 |
Why?
|
Computer Simulation | 2 | 2020 | 6194 | 0.140 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2021 | 1375 | 0.130 |
Why?
|
Microscopy | 1 | 2021 | 902 | 0.130 |
Why?
|
Animals | 16 | 2022 | 168770 | 0.130 |
Why?
|
Polyglycolic Acid | 2 | 2017 | 407 | 0.130 |
Why?
|
Pattern Recognition, Automated | 1 | 2021 | 1005 | 0.120 |
Why?
|
Heparin | 1 | 2021 | 1637 | 0.120 |
Why?
|
Blood Flow Velocity | 1 | 2018 | 1423 | 0.120 |
Why?
|
Pressure | 1 | 2017 | 1203 | 0.120 |
Why?
|
Humans | 22 | 2022 | 744376 | 0.110 |
Why?
|
Biological Transport | 1 | 2018 | 2120 | 0.110 |
Why?
|
Polymers | 3 | 2021 | 1621 | 0.110 |
Why?
|
Lung | 2 | 2022 | 9857 | 0.110 |
Why?
|
Recombinant Fusion Proteins | 1 | 2021 | 3773 | 0.110 |
Why?
|
Lab-On-A-Chip Devices | 1 | 2017 | 428 | 0.110 |
Why?
|
Disease Models, Animal | 3 | 2020 | 18034 | 0.110 |
Why?
|
Thrombolytic Therapy | 1 | 2021 | 2162 | 0.100 |
Why?
|
Protein-Lysine 6-Oxidase | 1 | 2012 | 59 | 0.100 |
Why?
|
Hemorheology | 1 | 2012 | 145 | 0.100 |
Why?
|
Stroke | 1 | 2015 | 9981 | 0.100 |
Why?
|
Mesenteric Arteries | 1 | 2012 | 183 | 0.100 |
Why?
|
Escherichia coli | 2 | 2021 | 4217 | 0.100 |
Why?
|
Cell Culture Techniques | 1 | 2019 | 1678 | 0.100 |
Why?
|
Blood Circulation | 1 | 2012 | 251 | 0.100 |
Why?
|
Lactic Acid | 2 | 2017 | 1132 | 0.100 |
Why?
|
Antigens, CD | 1 | 2021 | 4026 | 0.100 |
Why?
|
Blood Vessels | 1 | 2016 | 1125 | 0.090 |
Why?
|
Recombinant Proteins | 1 | 2019 | 6621 | 0.090 |
Why?
|
Drug Design | 1 | 2015 | 1076 | 0.090 |
Why?
|
Mammary Neoplasms, Experimental | 1 | 2012 | 520 | 0.080 |
Why?
|
Extracellular Matrix | 2 | 2019 | 1741 | 0.080 |
Why?
|
Platelet Function Tests | 2 | 2021 | 270 | 0.080 |
Why?
|
Particulate Matter | 1 | 2020 | 2529 | 0.080 |
Why?
|
Models, Anatomic | 1 | 2012 | 691 | 0.080 |
Why?
|
Models, Biological | 2 | 2021 | 9584 | 0.080 |
Why?
|
Femoral Artery | 2 | 2022 | 845 | 0.070 |
Why?
|
Protein Binding | 1 | 2019 | 9384 | 0.070 |
Why?
|
Mice | 7 | 2021 | 81202 | 0.070 |
Why?
|
Cells, Cultured | 2 | 2021 | 19233 | 0.070 |
Why?
|
Reference Standards | 2 | 2021 | 1025 | 0.070 |
Why?
|
Microfluidic Analytical Techniques | 1 | 2012 | 828 | 0.070 |
Why?
|
Islets of Langerhans | 1 | 2011 | 1352 | 0.060 |
Why?
|
Neovascularization, Physiologic | 2 | 2022 | 1351 | 0.060 |
Why?
|
Endovascular Procedures | 1 | 2015 | 1980 | 0.050 |
Why?
|
Ink | 1 | 2021 | 44 | 0.050 |
Why?
|
Methacrylates | 1 | 2021 | 107 | 0.050 |
Why?
|
Rabbits | 2 | 2019 | 4894 | 0.050 |
Why?
|
Bioengineering | 1 | 2021 | 99 | 0.050 |
Why?
|
Quorum Sensing | 1 | 2021 | 131 | 0.050 |
Why?
|
Mice, Inbred C57BL | 2 | 2021 | 21833 | 0.040 |
Why?
|
Mice, Inbred BALB C | 2 | 2019 | 6387 | 0.040 |
Why?
|
Immunosuppressive Agents | 1 | 2011 | 4153 | 0.040 |
Why?
|
Anastomosis, Surgical | 1 | 2022 | 987 | 0.040 |
Why?
|
Collagen Type I | 1 | 2021 | 592 | 0.040 |
Why?
|
Infarction, Middle Cerebral Artery | 1 | 2021 | 475 | 0.040 |
Why?
|
Morphogenesis | 1 | 2022 | 752 | 0.040 |
Why?
|
Rheology | 1 | 2019 | 345 | 0.040 |
Why?
|
Microscopy, Electron | 1 | 2021 | 2646 | 0.040 |
Why?
|
Suspensions | 1 | 2017 | 65 | 0.040 |
Why?
|
Excipients | 1 | 2017 | 96 | 0.040 |
Why?
|
Microbubbles | 1 | 2017 | 128 | 0.030 |
Why?
|
Communication | 2 | 2021 | 3750 | 0.030 |
Why?
|
Cell Proliferation | 1 | 2012 | 10484 | 0.030 |
Why?
|
Ultrasonics | 1 | 2017 | 212 | 0.030 |
Why?
|
Immunotherapy | 1 | 2011 | 4445 | 0.030 |
Why?
|
Hydrogels | 1 | 2021 | 724 | 0.030 |
Why?
|
Cell Line, Tumor | 3 | 2019 | 16692 | 0.030 |
Why?
|
Rats | 2 | 2022 | 24252 | 0.030 |
Why?
|
Blood-Brain Barrier | 1 | 2021 | 1019 | 0.030 |
Why?
|
Blood Coagulation | 1 | 2021 | 1127 | 0.030 |
Why?
|
Molecular Weight | 1 | 2017 | 2255 | 0.030 |
Why?
|
Perfusion | 1 | 2019 | 1360 | 0.030 |
Why?
|
Prostheses and Implants | 1 | 2021 | 1387 | 0.030 |
Why?
|
Microscopy, Confocal | 1 | 2019 | 1970 | 0.030 |
Why?
|
Swine | 1 | 2022 | 5918 | 0.030 |
Why?
|
Mice, Nude | 1 | 2019 | 3689 | 0.030 |
Why?
|
Flow Cytometry | 1 | 2021 | 5974 | 0.020 |
Why?
|
Doxorubicin | 1 | 2017 | 2234 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 1 | 2021 | 8300 | 0.020 |
Why?
|
Cattle | 1 | 2015 | 3922 | 0.020 |
Why?
|
Cardiovascular Diseases | 1 | 2015 | 15159 | 0.020 |
Why?
|
Receptors, Cell Surface | 1 | 2019 | 2866 | 0.020 |
Why?
|
Biocompatible Materials | 1 | 2017 | 1736 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2019 | 4851 | 0.020 |
Why?
|
Stem Cells | 1 | 2021 | 3567 | 0.020 |
Why?
|
Neoplasms | 1 | 2017 | 21693 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2019 | 3511 | 0.020 |
Why?
|
Male | 4 | 2021 | 350118 | 0.020 |
Why?
|
Imaging, Three-Dimensional | 1 | 2019 | 4042 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2015 | 8642 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2015 | 63115 | 0.010 |
Why?
|
Female | 2 | 2019 | 380200 | 0.010 |
Why?
|
Concepts
(146)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(4)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_